“Moonshot” Initiative to Hasten Cancer Cure
Vice President Joe Biden launched the “moonshot” initiative to hasten a cure for cancer at Philadelphia’s Abramson Cancer Center, where ACGT Fellows Dr. Carl June … Read More
News
Suicide Gene Therapy Safely and Successfully Kills Prostate Tumor Cells
Results of a long-term clinical trial have shown that combining chemotherapy with a treatment known as “suicide gene therapy,” can safely and successfully kill prostate tumor cells. ACGT researchers are also working with “suicide gene therapy”, using genetically modified cancer cells to trigger the body’s immune system to attack them. Read More
Immunotherapy Destroys Leukemia in Children
In a recent study of 53 children with the chronic form of lymphocytic leukemia, [CLL], 95% achieved complete remission, as well as 93 % of children with the more deadly form [ALL], using CAR T-cell therapy. The study had its roots in early research funded by ACGT. Read More
Patient in China Free of Leukemia After CAR T Cell Therapy
In China, a patient whose life was close to its end was completely cured of leukemia by stimulating the immune system using CAR T-cell therapy. … Read More
New Drugs Take Aim At Treatment-Resistant Cancers
Opdivo was recently approved by the FDA to treat advanced kidney cancer. Opdivo, and a similar drug, Keytruda, target molecular pathways known as PD-1/PD-L1 (proteins found on the body’s immune cells and some cancer cells). By blocking this pathway, Opdivo and Keytruda may help the body’s immune system fight the cancer cells. Read More
